Ozanezumab
id:
ozanezumab-296-9640898
title:
Ozanezumab
text:
Ozanezumab is a monoclonal antibody designed for the treatment of ALS and multiple sclerosis. Ozanezumab targets a protein called Neurite Outgrowth Inhibitor (NOGO-A) or Reticulon 4 (RTN4). NOGO-A is a protein that in humans is encoded by the RTN4 gene that has been identified as an inhibitor of neurite outgrowth specific to the central nervous system. NOGO-A is found at higher than normal levels in persons with ALS. This drug was developed by GlaxoSmithKline (GSK) under the identifier GSK 12232
brand slug:
wiki
category slug:
encyclopedia
description:
Monoclonal antibody
original url:
https://en.wikipedia.org/wiki/Ozanezumab
date created:
date modified:
2023-12-20T21:40:35Z
main entity:
{"identifier":"Q7116457","url":"https://www.wikidata.org/entity/Q7116457"}
image:
fields total:
13
integrity:
14